KKR-backed LGC acquires SeraCare from Linden

Linden Capital Partners has sold SeraCare Life Sciences to LGC North America Inc, which is backed by KKR. No financial terms were disclosed. Based in Milford, Massachusetts, SeraCare is a maker of biological products used in the discovery, production, and calibration of diagnostic assays.

DealsNorth AmericaUSHealthcareBriefs